Thursday, Nov 14th

7:30 AM Registration & Morning Coffee

Sponsored by Revolutionary Clinics

8:00 AM The Endocannabinoid and Phytocannabinoid Entourage Effects

Dr. Jokubas Ziburkus PhD & Chief Innovation Officer, MariMed Inc. - early hominins started their relationship with cannabis 28 million years ago. The earliest human and cannabis interactions have likely taken place 160,000 years ago in the Tibetan plane, inhabited by Denisovans. Cannabis is one of the few plants on the planet that can stimulate the human endocannabinoid system. Co-evolution of human endocannabinoid system (endocannabinoid molecules, cannabinoid receptors, and enzymes) and cannabis (phytocannabinoids, terpenes, and flavonoids) resulted in widespread modern medicinal uses of cannabis indica and industrial applications of cannabis sativa (hemp).  

Evolution of Cannabis: from Tibetan Planes to virus-induced coding of cannabinoids Human endocannabinoid system and its interaction with various components found in hemp. 

  • CBD actions on receptor targets, enzymes, metabolites
  • Hemp-derived products on the market
  • Most common bioactive molecules in hemp oils
  • How to read hemp product test results
  • Human - hemp product entourage effect 

The presentation will have the most up to date science and clinical evidence in a power point format.  Small handouts 'Hemp CBD Guide for Healthcare Practitioners' will serve as a handout to accompany the power point presentation.    

9:00 AM Cannabis is Healthcare

Keynote Speakers - MA State Rep. David LeBoeuf & Nichole Snow, Pres of MA Patient Advocacy Alliance (MPAA), Elizabeth Dost, RN & Clinical Director, MPAA

MPAA has never been closer to integrating cannabis into traditional healthcare. We'll share how MPAA won these essential legislative changes and discuss Mass House Bill H.3875 'an Act relative to insurance coverage of medicinal cannabis' garnered 10 co-sponsors from both the Massachusetts House and Senate.

9:30 AM Cannabis for Health Promotion and Disease Prevention

Keynote Speaker - Dustin Sulak DO, Founder reviews the evidence supporting the use of cannabis to not only treat disease, but to prevent disease and maintain health, with practical and easy-to-implement dosing strategies. This presentation also covers non-cannabis influences on our endocannabinoid physiology and focus on chronic conditions including sleep disorders, cardiovascular disease, neurologic injury, obesity and diabetes, and more.   

10:30 AM Networking Break, Exhibit Hall 

Sponsored by Healthy Hemp Solutions

10:45 AM  the Endocannabinoid System (ECS) and the Aging Population

Dr. Ryan Zaklin MD, MA, PC - the Endocannabinoid System (ECS), the physiological system responsible for maintaining balance in relation to ourselves and our environment is one of the most important discoveries of this last century. Cannabinoids are the diet of the ECS. 

11:45 AM "Cannabis as been touted as a Cure-All and as a Poison...what does the data tell us"

Panel Discussion,  Jordan Tishler, MD, Kate Schultz, MSN, NP-C, Brett Greene - session will address the risks of cannabis including dependence and addiction, and its influence on major mental illness. We’ll also dig deep and discuss the use of cannabis as an alternative to opioids and benzodiazepines, and its role, if any, in treating use disorders. 

12:30 PM Lunch Break 

1:15 PM an Approach to Breaking Down the Opioid Crisis

Dr. Michelle Shuffett - In most states with a medical cannabis program, severe or chronic pain are considered qualifying conditions and many patients are turning to medical cannabis as an alternative to opioids  This session will explore the use of medical cannabis for pain relief, its impact on the opioid epidemic, and the risk of addiction/dependence.  

2:00 PM Integrative Approaches to Optimizing the Endocannabinoid System

Panel Discussion, Dustin Sulak DO, Ryan Zaklin, MD, MA, PC and Marissa Fratoni, RN (Moderator) - will discuss and focus on the role that mind-body practices and other healthy lifestyle choices contribute to optimal functioning of the Endocannabinoid System (ECS). How to address ECS dysfunction without the use of cannabis will be examined. 

2:45 PM  A Chronic Problem; Suffering in America 

Elizabeth G. Dost, RN, & Clinical Director, Mass Patient Advocacy Alliance - In the year 2019, suffering in America is seemingly at an all-time high, yet we turn a deaf ear to the cries of those in anguish. Federal prohibition of cannabis continues, as patients are being forced-tapered off long term opioids, doctors intimidated and the ‘new’ pain standard treatment is Tylenol and Motrin, even as this is defined as a violation of WHO standards against war crimes.  Let’s explore the social impact of unmitigated suffering as we attempt to answer Primo Levi’s famous call; ‘If we know there is suffering and we do nothing to alleviate it, we ourselves become the tormentors‘.

3:30 PM Networking Break, Exhibit Hall 

Sponsored by Healthy Hemp Solutions

3:45 PM Temescal Wellness is the Life Cannabis Company, 

Philip Poirier, Director, Retail Temescal Wellness  

3:50 PM Cannabis Dosing Distilled 

Dustin Sulak DO - a decade of clinical experience, shares his methods for creating personalized treatment plans, including relevant background information on cannabis dose-response effects, delivery method selection, strategies for the cannabis naive, experienced users, opioid-dependence, seizures, and more. 

5:00 PM Welcome Networking Cocktail Reception  

6:00 PM End of Day 1

Friday, Nov 15th

8:00 AM Morning Coffee 

8:30 AM Clinical Applications and the Future of Cannabis Derived Products - Panel Discussion, Dr. Jokubas Ziburkus & Dr. Eva Selhub - consumers and medical professionals currently have access to a variety of products and formats. Clinical applications of medical cannabis and hemp-derived CBD are increasing, yet clinical research and disease-specific validation of cannabis products is still lacking.

Four key pillars in cannabis alternative therapy are; 

  • State of individual’s endocannabinoid system
  • Possible drug-drug and system-system interactions with existing supplements of pharmaceuticals 
  • Precise composition and reproducibility of the products (third party tested products with detailed analysis of phytocannabinoids and terpenes) 
  • Condition and product-specific clinical efficacy and safety studies 

9:30 AM the Effects of CBD in Pediatrics

Dr. Jenny Wilkins - will be explaining the Endocannabinoid System (ECS) and how CBD can replace the need for over-the-counter medications in both adults and children, getting them back on track for a happier and healthier life. 

10:15 AM Networking Break, Exhibit Hall 

Sponsored by Healthy Hemp Solutions

10:30 AM Building a Medical Cannabis Process and System

Keynote Speaker - Dr. Jordan Tishler

Here we will discuss the history and development of the pharmacy industry from a regulatory standpoint, and the lessons both the federal government and the industry can take away. The integrity of our existing system is flawed as this not only harms patients desperately seeking the care and relief they need, but undermines the very trust on which a medical system must enact and abide by.    

11:30 AM Revolutionary Clinics - Medicinal Cannabis for Patients, 

Deidra Ruvido, Director of Business Development

11:35 AM  In How to Stop the Top Killers 

Dr. Mary Clifton - examines the top causes of death in America—heart disease, cancer, diabetes, Alzheimer’s, high blood pressure, and further explains how cannabinoids can prevent and reverse disease and extend life. As a licensed practitioner, Mary Clifton MD consults with individuals and organizations to increase access for patients and normalize cannabinoid use. 

12:30 PM Lunch on own  

1:15 PM Pharmacy Practice Model

Rahim Dhalla, PharmD RPh - 

This talk will dive into current best practices as well as look into compounding with cannabis for specific patient populations. We will share our successes and challenges in developing Canada’s first cannabis specialty pharmacy; Hybrid Pharm 

2:00 PM Safety Hack: Minimize Cannabis Toxicity

Dr. Melani Kane (Bersten), PharmD - will discuss and provide an in-depth review of the possible side effects and drug interactions with the use of Cannabinoid medicine. Audience members will review unique patient cases and develop recommendations to relieve toxicity. 

2:30 PM American Cannabis Nurses Association (ACNA)

Carey Clark, President of ACNA - 

The National Council of States Boards of Nurses (NCSBN) has issued a call that all nursing students be educated on the 6 essential areas of medical cannabis care. This talk discusses the implications of the NCSBN call, the work that that the American Cannabis Nurses Association is undertaking to help support the education of nurses around cannabis care, and the forthcoming Wolters Kluwer publication of the textbook Cannabis: A Handbook for Nurses.

3:00 PM Networking Break, Exhibit Hall 

Sponsored by Healthy Hemp Solutions

3:15 PM the Cannabis Nurse Experience

Sherri Tutkus, RN, BSN - CEO GreenNurse Group This session will explore how cannabis nurses utilize their working knowledge of the Endocannabinoid System, Cannabis Pharmacology and current evidence for the purpose of helping patients access and effectively use cannabis as medicine. Further,  examine the various aspects in which a cannabis nurse my provide consultation and education while considering associated legal implications.

3:45 PM the Cannabis Nurse Experience

Panel Discussion, Sherri Tutkus, RN, BSN, Jodi Chapin, RN, Marissa Fratoni, RN Tonya Sanders, RN and Nique Pichette, MSN, RN - sharing their knowledge and experience of being and becoming an educated cannabis nurse and further how to overcome the legal and career challenges in an ever growing cannabis healthcare economy. 

4:30 PM End of Conference